MARKET

POAI

POAI

Predictive Oncology Inc
NASDAQ
1.751
-0.029
-1.62%
Opening 15:17 04/12 EDT
OPEN
1.860
PREV CLOSE
1.780
HIGH
1.890
LOW
1.720
VOLUME
9.28K
TURNOVER
0
52 WEEK HIGH
13.88
52 WEEK LOW
1.680
MARKET CAP
7.11M
P/E (TTM)
-0.5028
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at POAI last week (0401-0405)?
Weekly Report · 4d ago
Weekly Report: what happened at POAI last week (0325-0329)?
Weekly Report · 04/01 12:07
Predictive Oncology GAAP EPS of -$3.48, revenue of $1.78M
Earnings News Predictive Oncology GAAP EPS of -$3.48, revenue of $1.78M (+17.9% Y/Y). Net cash used in operating activities was $13.19M in 2023, compared to $12.37M in 2022.
Seeking Alpha · 03/29 05:12
Predictive Oncology Q4 EPS $(0.85) Up From $(2.00) YoY, Sales $335.03K Down From $363.47K YoY
Predictive Oncology reported quarterly losses of $0.85 per share. The company reported $335.03 thousand in sales for the quarter. This is a 7.82 percent decrease over sales of $363.47 thousand in the same period last year.
Benzinga · 03/29 04:59
POAI Stock Earnings: Predictive Oncology Reported Results for Q4 2023
Predictive Oncology reported results for the fourth quarter of 2023. The company reported earnings per share of -85 cents and revenue of $335,032. Predictive oncology is a biopharmaceutical company with a focus on cancer treatment and research.
Investorplace · 03/29 03:52
Predictive Oncology Inc: Annual report
Press release · 03/29 02:11
*Predictive Oncology 2023 Loss/Shr $3.48 >POAI
Dow Jones · 03/28 21:53
*Predictive Oncology 2023 Rev $1.8M >POAI
Dow Jones · 03/28 21:53
More
About POAI
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates through three segments: Pittsburgh, Birmingham, and Eagan. Pittsburgh segment provides services, which include the application of artificial intelligence (AI) using its proprietary biobank of 150,000 plus tumor samples. Pittsburgh segment also develops tumor-specific in vitro models for oncology drug discovery and research. Birmingham segment focuses on contract services and research for biopharmaceutical company clients and academic collaborators, focused on solubility improvements, stability studies, and protein production. Specifically, Birmingham provides optimized formulations for vaccines, antibodies, and other protein therapeutics. Eagan segment produces the STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal.

Webull offers Predictive Oncology Inc stock information, including NASDAQ: POAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, POAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading POAI stock methods without spending real money on the virtual paper trading platform.